
Thoracic vascular grafts are medical devices used in vascular surgery to treat conditions affecting the thoracic aorta and its branches. These grafts are designed to repair or replace damaged blood vessels in the thoracic region, including the ascending aorta, aortic arch, and descending thoracic aorta.
The global market for Thoracic Vascular Graft was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Thoracic Vascular Graft, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Thoracic Vascular Graft by region & country, by Type, and by Application.
The Thoracic Vascular Graft market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Thoracic Vascular Graft.
麻豆原创 Segmentation
By Company
Terumo
Medtronic
Gore Medical
Getinge Group
LeMaitre Vascular
B.Braun
CryoLife
Cook Medical
Bard
Vascutek Ltd.
Japan Lifeline
Lombard Medical
Segment by Type:
Polyester Graft
PTFE Graft
Others
Segment by Application
Aortic Aneurysm
Aortic Dissection
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Thoracic Vascular Graft manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Thoracic Vascular Graft in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Thoracic Vascular Graft in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 麻豆原创 Overview
1.1 Thoracic Vascular Graft Product Introduction
1.2 Global Thoracic Vascular Graft 麻豆原创 Size Forecast
1.2.1 Global Thoracic Vascular Graft Sales Value (2019-2030)
1.2.2 Global Thoracic Vascular Graft Sales Volume (2019-2030)
1.2.3 Global Thoracic Vascular Graft Sales Price (2019-2030)
1.3 Thoracic Vascular Graft 麻豆原创 Trends & Drivers
1.3.1 Thoracic Vascular Graft Industry Trends
1.3.2 Thoracic Vascular Graft 麻豆原创 Drivers & Opportunity
1.3.3 Thoracic Vascular Graft 麻豆原创 Challenges
1.3.4 Thoracic Vascular Graft 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Thoracic Vascular Graft Players Revenue Ranking (2023)
2.2 Global Thoracic Vascular Graft Revenue by Company (2019-2024)
2.3 Global Thoracic Vascular Graft Players Sales Volume Ranking (2023)
2.4 Global Thoracic Vascular Graft Sales Volume by Company Players (2019-2024)
2.5 Global Thoracic Vascular Graft Average Price by Company (2019-2024)
2.6 Key Manufacturers Thoracic Vascular Graft Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Thoracic Vascular Graft Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Thoracic Vascular Graft
2.9 Thoracic Vascular Graft 麻豆原创 Competitive Analysis
2.9.1 Thoracic Vascular Graft 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Thoracic Vascular Graft Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thoracic Vascular Graft as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Polyester Graft
3.1.2 PTFE Graft
3.1.3 Others
3.2 Global Thoracic Vascular Graft Sales Value by Type
3.2.1 Global Thoracic Vascular Graft Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Thoracic Vascular Graft Sales Value, by Type (2019-2030)
3.2.3 Global Thoracic Vascular Graft Sales Value, by Type (%) (2019-2030)
3.3 Global Thoracic Vascular Graft Sales Volume by Type
3.3.1 Global Thoracic Vascular Graft Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Thoracic Vascular Graft Sales Volume, by Type (2019-2030)
3.3.3 Global Thoracic Vascular Graft Sales Volume, by Type (%) (2019-2030)
3.4 Global Thoracic Vascular Graft Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Aortic Aneurysm
4.1.2 Aortic Dissection
4.1.3 Other
4.2 Global Thoracic Vascular Graft Sales Value by Application
4.2.1 Global Thoracic Vascular Graft Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Thoracic Vascular Graft Sales Value, by Application (2019-2030)
4.2.3 Global Thoracic Vascular Graft Sales Value, by Application (%) (2019-2030)
4.3 Global Thoracic Vascular Graft Sales Volume by Application
4.3.1 Global Thoracic Vascular Graft Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Thoracic Vascular Graft Sales Volume, by Application (2019-2030)
4.3.3 Global Thoracic Vascular Graft Sales Volume, by Application (%) (2019-2030)
4.4 Global Thoracic Vascular Graft Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Thoracic Vascular Graft Sales Value by Region
5.1.1 Global Thoracic Vascular Graft Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Thoracic Vascular Graft Sales Value by Region (2019-2024)
5.1.3 Global Thoracic Vascular Graft Sales Value by Region (2025-2030)
5.1.4 Global Thoracic Vascular Graft Sales Value by Region (%), (2019-2030)
5.2 Global Thoracic Vascular Graft Sales Volume by Region
5.2.1 Global Thoracic Vascular Graft Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Thoracic Vascular Graft Sales Volume by Region (2019-2024)
5.2.3 Global Thoracic Vascular Graft Sales Volume by Region (2025-2030)
5.2.4 Global Thoracic Vascular Graft Sales Volume by Region (%), (2019-2030)
5.3 Global Thoracic Vascular Graft Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Thoracic Vascular Graft Sales Value, 2019-2030
5.4.2 North America Thoracic Vascular Graft Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Thoracic Vascular Graft Sales Value, 2019-2030
5.5.2 Europe Thoracic Vascular Graft Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Thoracic Vascular Graft Sales Value, 2019-2030
5.6.2 Asia Pacific Thoracic Vascular Graft Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Thoracic Vascular Graft Sales Value, 2019-2030
5.7.2 South America Thoracic Vascular Graft Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Thoracic Vascular Graft Sales Value, 2019-2030
5.8.2 Middle East & Africa Thoracic Vascular Graft Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Thoracic Vascular Graft Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Thoracic Vascular Graft Sales Value
6.2.1 Key Countries/Regions Thoracic Vascular Graft Sales Value, 2019-2030
6.2.2 Key Countries/Regions Thoracic Vascular Graft Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Thoracic Vascular Graft Sales Value, 2019-2030
6.3.2 United States Thoracic Vascular Graft Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Thoracic Vascular Graft Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Thoracic Vascular Graft Sales Value, 2019-2030
6.4.2 Europe Thoracic Vascular Graft Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Thoracic Vascular Graft Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Thoracic Vascular Graft Sales Value, 2019-2030
6.5.2 China Thoracic Vascular Graft Sales Value by Type (%), 2023 VS 2030
6.5.3 China Thoracic Vascular Graft Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Thoracic Vascular Graft Sales Value, 2019-2030
6.6.2 Japan Thoracic Vascular Graft Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Thoracic Vascular Graft Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Thoracic Vascular Graft Sales Value, 2019-2030
6.7.2 South Korea Thoracic Vascular Graft Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Thoracic Vascular Graft Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Thoracic Vascular Graft Sales Value, 2019-2030
6.8.2 Southeast Asia Thoracic Vascular Graft Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Thoracic Vascular Graft Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Thoracic Vascular Graft Sales Value, 2019-2030
6.9.2 India Thoracic Vascular Graft Sales Value by Type (%), 2023 VS 2030
6.9.3 India Thoracic Vascular Graft Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Terumo
7.1.1 Terumo Company Information
7.1.2 Terumo Introduction and Business Overview
7.1.3 Terumo Thoracic Vascular Graft Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Terumo Thoracic Vascular Graft Product Offerings
7.1.5 Terumo Recent Development
7.2 Medtronic
7.2.1 Medtronic Company Information
7.2.2 Medtronic Introduction and Business Overview
7.2.3 Medtronic Thoracic Vascular Graft Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Medtronic Thoracic Vascular Graft Product Offerings
7.2.5 Medtronic Recent Development
7.3 Gore Medical
7.3.1 Gore Medical Company Information
7.3.2 Gore Medical Introduction and Business Overview
7.3.3 Gore Medical Thoracic Vascular Graft Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Gore Medical Thoracic Vascular Graft Product Offerings
7.3.5 Gore Medical Recent Development
7.4 Getinge Group
7.4.1 Getinge Group Company Information
7.4.2 Getinge Group Introduction and Business Overview
7.4.3 Getinge Group Thoracic Vascular Graft Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Getinge Group Thoracic Vascular Graft Product Offerings
7.4.5 Getinge Group Recent Development
7.5 LeMaitre Vascular
7.5.1 LeMaitre Vascular Company Information
7.5.2 LeMaitre Vascular Introduction and Business Overview
7.5.3 LeMaitre Vascular Thoracic Vascular Graft Sales, Revenue and Gross Margin (2019-2024)
7.5.4 LeMaitre Vascular Thoracic Vascular Graft Product Offerings
7.5.5 LeMaitre Vascular Recent Development
7.6 B.Braun
7.6.1 B.Braun Company Information
7.6.2 B.Braun Introduction and Business Overview
7.6.3 B.Braun Thoracic Vascular Graft Sales, Revenue and Gross Margin (2019-2024)
7.6.4 B.Braun Thoracic Vascular Graft Product Offerings
7.6.5 B.Braun Recent Development
7.7 CryoLife
7.7.1 CryoLife Company Information
7.7.2 CryoLife Introduction and Business Overview
7.7.3 CryoLife Thoracic Vascular Graft Sales, Revenue and Gross Margin (2019-2024)
7.7.4 CryoLife Thoracic Vascular Graft Product Offerings
7.7.5 CryoLife Recent Development
7.8 Cook Medical
7.8.1 Cook Medical Company Information
7.8.2 Cook Medical Introduction and Business Overview
7.8.3 Cook Medical Thoracic Vascular Graft Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Cook Medical Thoracic Vascular Graft Product Offerings
7.8.5 Cook Medical Recent Development
7.9 Bard
7.9.1 Bard Company Information
7.9.2 Bard Introduction and Business Overview
7.9.3 Bard Thoracic Vascular Graft Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Bard Thoracic Vascular Graft Product Offerings
7.9.5 Bard Recent Development
7.10 Vascutek Ltd.
7.10.1 Vascutek Ltd. Company Information
7.10.2 Vascutek Ltd. Introduction and Business Overview
7.10.3 Vascutek Ltd. Thoracic Vascular Graft Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Vascutek Ltd. Thoracic Vascular Graft Product Offerings
7.10.5 Vascutek Ltd. Recent Development
7.11 Japan Lifeline
7.11.1 Japan Lifeline Company Information
7.11.2 Japan Lifeline Introduction and Business Overview
7.11.3 Japan Lifeline Thoracic Vascular Graft Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Japan Lifeline Thoracic Vascular Graft Product Offerings
7.11.5 Japan Lifeline Recent Development
7.12 Lombard Medical
7.12.1 Lombard Medical Company Information
7.12.2 Lombard Medical Introduction and Business Overview
7.12.3 Lombard Medical Thoracic Vascular Graft Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Lombard Medical Thoracic Vascular Graft Product Offerings
7.12.5 Lombard Medical Recent Development
8 Industry Chain Analysis
8.1 Thoracic Vascular Graft Industrial Chain
8.2 Thoracic Vascular Graft Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Thoracic Vascular Graft Sales Model
8.5.2 Sales Channel
8.5.3 Thoracic Vascular Graft Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Terumo
Medtronic
Gore Medical
Getinge Group
LeMaitre Vascular
B.Braun
CryoLife
Cook Medical
Bard
Vascutek Ltd.
Japan Lifeline
Lombard Medical
听
听
*If Applicable.
